Executive Briefing Series (formerly The Food & Drug Letter)
Nov. 2, 2012
FDA Releases Lists of NECC Customers Possibly Receiving Contaminated Drugs
The FDA has released two lists of customers that received products shipped on or after May 21 from New England Compounding Center’s (NECC) Framingham, Mass., facility.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|